The ReSurge trial could achieve an increasing recruitment rate during the last year. This is great, especially in view of the pandemia which accompanies us for over a year now. We’d like to thank all trial teams from all centers for their effort and persistance. We count now 59 patients from a total of 27…
Read more
Also the newly opened sites in Larisa, Erfurt and Mainz could recuit their first patient. Moreover, one more patient was recruited in Lausanne and six in Bern.In total 36 patients are participating in the trial.
We very welcome Universitair Medische Centra in Amsterdam with their principal investigator Dr. Philip de Witt Hamer to the ReSurge trial team. Not long after recruitment start, the first patient was included into the RCT group – congratulations!
We very welcome to the ReSurge community the clinical investigation center of the University Hospital of Lisboa and the Neurosurgery division of the University Hospital of Alberta, Canada.
We are very happy to welcome the Trial Teams in Bucharest, Thessaloniki, Larissa, Köln and Frankfurt to the Resurge Study.
The site Lausanne included another patient! A total of 25 patients are now part of the trial.
On December 4th the Resurge Team in Lausanne included their fifth Patient in the Trial. Bern included their 16th patient on January 8th. This means 24 patients in total are part of the trial.
We are very happy to welcome the Trial Team in Freiburg on board the Resurge Study.
This week we included the 15th patient in Bern. We recruited 22 patients in total into the trial so far.
The investigators of the reSurge Study group will meet at this years EANS conference (October 23rd) in Brussels for update, exchange of experiences and coffee.